Safety protocols protect both the integrity of the peptide and the researcher
Bedrijfsprofiel Onze opdrachtgever is een wereldwijd farmaceutische onderneming
References Godlewska BR, Williams S, Emir UE, Chen C, Sharpley AL, Goncalves AJ, et al
Metabolic Disease Model Research Laboratory studies investigate AOD9604 in metabolic contexts: Obesity Models: Research in diet-induced obesity examining fat mass reduction mechanisms Insulin Resistance: Studies assessing metabolic improvements without insulin antagonism Hepatic Steatosis: Investigation of liver fat reduction through enhanced peripheral lipolysis Metabolic Syndrome: Research on multiple metabolic parameter improvements Comparison to GH: Assessment of metabolic benefits without GH receptor-mediated side effects Experimental protocols evaluate whether selective lipolytic stimulation provides metabolic benefits with improved safety profile
[DOI] [PubMed] [Google Scholar] Konig SA, Siemes H, Blaker F, Boenigk E, Gross-Selbeck G, Hanefeld F, Haas N, Kohler B, Koelfen W, Korinthenberg R, et al